Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline.

doi:10.1200/JCO.23.02225

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 Feb 2024

Bedrosian Isabelle, Somerfield Mark R, Achatz Maria Isabel, Boughey Judy C, Curigliano Giuseppe, Friedman Sue, Kohlmann Wendy K, Kurian Allison W, Laronga Christine, Lynce Filipa, Norquist Barbara S, Plichta Jennifer K, Rodriguez Patricia, Shah Payal D, Tischkowitz Marc, Wood Marie, Yadav Siddhartha, Yao Katherine, Robson Mark E

Abstract excerpt

PURPOSE: To develop recommendations for germline mutation testing for patients with breast cancer. METHODS: An ASCO-Society of Surgical Oncology (SSO) panel convened to develop recommendations based on a systematic review and formal consensus process. RESULTS: Forty-seven articles met eligibility criteria for the germline mutation testing recommendations; 18 for the genetic counseling recommendations....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA2 Protein

Share to Breast Neoplasms

Share to Genetic Testing

Share to Germ Cells

Share to Germ-Line Mutation

Share to Neoplasm Recurrence, Local

Share to Risk Assessment

Source

Open in PubMed

Identifiers

PMID: 38175972
DOI: 10.1200/JCO.23.02225

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline.PMID 38175972Read ↗

Genetic testing in women with breast cancer: implications for treatment.Semantic proximity Read ↗

Management Strategies of Breast Cancer Patients with BRCA1 and BRCA2 Pathogenic Germline VariantsSemantic proximity Read ↗

Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline.Semantic proximity Read ↗

Utility of Expedited Hereditary Cancer Testing in the Surgical Management of Patients with a New Breast Cancer Diagnosis.Semantic proximity Read ↗

Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline.Semantic proximity Read ↗

Cancer treatment according to BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working GroupSemantic proximity Read ↗

Molecular Testing in Breast Cancer: A Guide to Current Practices.Semantic proximity Read ↗

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.Semantic proximity Read ↗

Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer.Semantic proximity Read ↗

Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing.Semantic proximity Read ↗

Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast SurgeonsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.